Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 443 results for "hetero drugs"

Natco, Hetero get DCGI nod to sell hepatitis C treatment drug
The Freepress Journal

Natco, Hetero get DCGI nod to sell hepatitis C treatment drug

New Delhi: Drug makers Natco Pharma and Hetero have got approval from the Drugs Controller General of India (DCGI) to sell generic version of Daclatasvir, used for treatment of chronic hepatitis C. In a BSE filing today, Natco Pharma said: It is ... The Freepress Journal, 1 month ago
Generic antivirals a booster dose forHepatitis C Hindustan Times, 1 month ago

2 images for "hetero drugs"

The Hindu, 1 day ago, 5 days ago

Hetero Drugs Limited - Product Pipeline Review - 2015

Summary 's, ' ', provides an overview of the Hetero Drugs Limited's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Hetero Drugs Limited's, ...
 Global Information Inc1 week ago

Cipla to sell hepatitis C drug Daclatasvir

Emcure, Hetero and Natco also get sub-licence to sell generic version of Bristol-Myers Squibbs drug
 Business Standard3 weeks ago Cipla, Emcure, Hetero and Natco Pharma join patent pool for new Hepatitis C drug Daclatavir  Economic Times3 weeks ago

Indian drug firms dip into patent pool for Hep C drug

Indian drugmakers Cipla, Emcure, Hetero and Natco have received the first round of sub-licences from the Medicines Patent Pool (MPP) to make generic versions of Bristol-Myers Squibb's hepatitis C drug daclatasvir. The development marks a first for ...
 Hindu Business Line2 weeks ago Medicines Patent Pool administers sub-licenses for generic production of Daklinza  Orthopedics Today2 weeks ago BRISTOL MYERS SQUIBB : CIPLA -The Medicines Patent Pool Signs First Sub-licences for Hepatitis C Medicine Daclatasvir  4 Traders2 weeks ago Sub-license for Hepatitis C drug beneficial for patients: Cipla  Moneycontrol.com2 weeks ago

Generic version of Daclatasvir tablets gets Drug Controller's approval

Hetero announced it has received approval from Drug Controller General of India for generic version of Daclatasvir tablets (30mg, 60mg). The product in combination with Sofosbuvir is indicated for the treatment of Hepatitis C genotype 3, says a company ...
 Times of India1 month ago Hetero receives drug controller approval for generic Daclatasvir  Economic Times1 month ago

The Manly Pursuit of Desire: Islam and the Fear of Compulsory Heterosexuality

"I would like to call you by a word that was never told before A word worth all this love ... A word to show my longings and passion A word like you . . . " Amal Hayati ("The Hope of My Life"), song by Umm Koultum. I have just finished reading ...
 Huffington Post1 month ago

Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt-based anti-cancer drugs

Introduction The platinumÔÇÉcontaining drugs cisplatin, carboplatin, and oxaliplatin are among the most successful drugs used for treating cancer (Kelland, 2007 ). Pt drugs introduce covalent adducts in DNA which eventually cause cell death. Tumor ...
 EMBO Journal1 month ago
Med India

Natco Pharma and Hetero Receives Indian Drug Regulatory Approval for Hepatitis-C Drug

Two Hyderabad-based drug companies, Natco Pharma and Hetero have received approval for the sale of Hepatitis- C drug from the Drugs Controller General of India (DCGI). The generic version of the drug, Daclatasvir Dihydrochloride (Daclatasvir) is the ...
 Med India1 month ago

Three new agreements announced with potential to expand access to innovative HIV treatment in low- and middle-income countries

UNITAID Logo Bringing effective new HIV drugs to the millions of people who have still not initiated treatment is a big challenge in global health today. UNITAID Executive Director Lelio Marmora (PRWEB UK) 1 December 2015 These ...
 PRWeb2 months ago Africa: Three New Agreements Announced With the Potential to Expand Access to Innovative HIV Treatment in Low - and Middle-Income Countries  AllAfrica.com2 months ago

Heterozygous familial hypercholesterolemia (heFH) Global Clinical Trials Review, H2, 2015

... LONDON Jan. 28 2016 /- Hetero...Download the full report: ... LONDON , Jan. 28, 2016 /PRNewswire/ -- Summary GlobalData's clinical trial report, " Heterozygous familial hypercholesterolemia (heFH) Global Clinical Trials Review, H2, 2015" ...
 Bio-Medicine1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - hetero drugs
Get updated on latest news & your favorite topics right in your inbox!
More     Less